How He Maintained A Staggering 97% Trading Win Rate Over 6+ Years

Economic Downturns, Pandemics, Wars—Nothing Shakes His Portfolio. He's Had Unearthly Wins In Both Bull And Bear Markets.

For Close To A Decade, He’s Maintained A Staggering 97% Trading Win Rate. He Didn't Follow The Wall Street Playbook, And Still Became A Millionaire Trader By The Age Of 37!

Watch His Exclusive Tell-All Interview Here Now

CERS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.05%

Insider Buying (Last 12 Months): $22,675.00

Insider Selling (Last 12 Months): $417,201.00

Cerus Insider Trading History Chart

Cerus Share Price & Price History

^$1.50

▼ -0.01 (-0.66%)

As of 09/22/2023 01:00 AM ET

Days: 30 | 90 | 365

MarketBeat's Top 5 Stock Picks - Just Released

From MarketBeat | Ad

MarketBeat has just released five new trading ideas to All Access subscribers, but Tesla, Apple, and Netflix didn't make the cut. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Now, MarketBeat thinks these five stocks may be even better buys.

View the Stocks Here

Cerus Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/22/2023	Ann Lucena	Director	Buy	7,500	$1.69	$12,675.00	72,284
5/23/2023	Eric Bjerkholt	Director	Buy	5,000	$2.00	$10,000.00	82,133
3/13/2023	Carol Moore	SVP	Sell	13,078	$2.80	$36,618.40	407,598
3/13/2023	Chrystal Menard	Insider	Sell	15,468	$2.80	$43,310.40	338,621
3/13/2023	Kevin Dennis Green	CFO	Sell	17,163	$2.80	$48,056.40	421,797
3/13/2023	Vivek K Jayaraman	COO	Sell	25,356	$2.80	$70,996.80	641,861
3/13/2023	William Mariner Greenman	CEO	Sell	60,480	$2.80	$169,344.00	2,616,411
11/10/2022	Daniel N. Swisher, Jr.	Director	Sell	12,500	$3.91	$48,875.00	113,808
8/9/2022	Richard J Benjamin	Insider	Sell	10,000	$5.12	$51,200.00	172,665
5/10/2022	Kevin Dennis Green	CFO	Sell	57,335	$4.98	$285,528.30	222,999
3/14/2022	Carol Moore	SVP	Sell	28,513	$5.04	$143,705.52
3/14/2022	Kevin Dennis Green	CFO	Sell	32,102	$5.04	$161,794.08
3/14/2022	Laurence M. Corash	Insider	Sell	30,307	$5.04	$152,747.28
3/14/2022	Vivek K Jayaraman	COO	Sell	41,734	$5.04	$210,339.36
3/14/2022	William Mariner Greenman	CEO	Sell	165,021	$5.04	$831,705.84
2/25/2022	William Mariner Greenman	CEO	Sell	308,263	$5.70	$1,757,099.10
1/3/2022	Carol Moore	SVP	Sell	19,059	$7.00	$133,413.00
11/9/2021	Gail Schulze	Director	Sell	25,000	$7.54	$188,500.00
11/5/2021	Carol Moore	SVP	Sell	110,000	$7.94	$873,400.00
11/3/2021	Chrystal Menard	Insider	Sell	40,000	$7.70	$308,000.00
11/3/2021	Kevin Dennis Green	CFO	Sell	95,741	$7.00	$670,187.00
8/4/2021	Daniel N. Swisher, Jr.	Director	Sell	12,877	$6.25	$80,481.25	106,231
5/18/2021	Daniel N. Swisher, Jr.	Director	Sell	5,000	$5.75	$28,750.00	64,868
3/15/2021	Carol Moore	SVP	Sell	29,331	$6.38	$187,131.78
3/15/2021	Laurence M. Corash	Insider	Sell	23,775	$6.38	$151,684.50	1,913,391
3/15/2021	Vivek K. Jayaraman	COO	Sell	37,149	$6.38	$237,010.62
3/15/2021	William Mariner Greenman	CEO	Sell	156,407	$6.38	$997,876.66
2/8/2021	Chrystal Menard	Insider	Sell	8,125	$8.00	$65,000.00	52,752
12/22/2020	Chrystal Menard	Insider	Sell	211,327	$8.00	$1,690,616.00	134,001
12/22/2020	Timothy B Anderson	Director	Sell	39,336	$8.31	$326,882.16	240,101
12/22/2020	Vivek K Jayaraman	COO	Sell	56,105	$8.00	$448,840.00	188,440
12/14/2020	Gail Schulze	Director	Sell	62,393	$7.32	$456,716.76	62,393
12/11/2020	Chrystal Menard	Insider	Sell	41,363	$8.00	$330,904.00	52,742
11/17/2020	Daniel N. Swisher, Jr.	Director	Sell	10,000	$6.25	$62,500.00	69,868
11/10/2020	Kevin Dennis Green	CFO	Sell	32,928	$5.49	$180,774.72	130,253

How A.I. Could Make Most 21st Century Diseases EXTINCT

From Behind the Markets | Ad

On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...

Get the name of the stock now... before it's too late

SEC Filings (Institutional Ownership Changes) for Cerus (NASDAQ:CERS)

81.72% of Cerus stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cerus Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/1/2023	Portside Wealth Group LLC	28,251	$70K	0.0%	N/A	0.016%
8/16/2023	Nuveen Asset Management LLC	1,327,269	$3.27M	0.0%	+8.9%	0.734%
8/15/2023	Wells Fargo & Company MN	107,544	$0.27M	0.0%	+64.3%	0.059%
8/15/2023	Integrated Wealth Concepts LLC	31,586	$78K	0.0%	-62.2%	0.017%
8/15/2023	Raymond James Trust N.A.	19,000	$47K	0.0%	-72.1%	0.011%
8/15/2023	XTX Topco Ltd	100,776	$0.25M	0.0%	-34.2%	0.056%
8/15/2023	Goldman Sachs Group Inc.	384,675	$0.95M	0.0%	-37.9%	0.213%
8/15/2023	Point72 Asset Management L.P.	111,400	$0.27M	0.0%	-89.5%	0.062%
8/15/2023	Royal Bank of Canada	19,286	$47K	0.0%	-77.7%	0.011%
8/15/2023	Silverarc Capital Management LLC	1,158,265	$2.85M	0.9%	+0.5%	0.641%
8/15/2023	Stifel Financial Corp	202,357	$0.50M	0.0%	+5.6%	0.112%
8/15/2023	Capital Impact Advisors LLC	129,404	$0.32M	0.3%	+7.0%	0.072%
8/14/2023	Stephens Inc. AR	256,939	$0.63M	0.0%	-4.2%	0.142%
8/14/2023	State of Wyoming	27,788	$68K	0.0%	+26.9%	0.015%
8/14/2023	State of Wisconsin Investment Board	14,042	$35K	0.0%	-37.2%	0.008%
8/14/2023	State Street Corp	5,142,789	$12.65M	0.0%	+6.9%	2.844%
8/14/2023	UniSuper Management Pty Ltd	1,182,281	$2.91M	0.0%	N/A	0.654%
8/14/2023	Nuveen Asset Management LLC	1,327,269	$3.27M	0.0%	+8.9%	0.734%
8/14/2023	Polar Capital Holdings Plc	1,276,781	$3.14M	0.0%	-45.4%	0.706%
8/14/2023	Silvercrest Asset Management Group LLC	2,585,847	$6.36M	0.0%	+17.3%	1.430%
8/14/2023	Graham Capital Management L.P.	12,252	$30K	0.0%	N/A	0.007%
8/11/2023	Renaissance Technologies LLC	443,300	$1.09M	0.0%	-42.1%	0.245%
8/11/2023	Senvest Management LLC	5,451,088	$13.41M	0.4%	-1.9%	3.015%
8/11/2023	Baird Financial Group Inc.	11,950	$29K	0.0%	-71.8%	0.007%
8/11/2023	Credit Suisse AG	280,185	$0.69M	0.0%	+2.8%	0.155%
8/11/2023	BlackRock Inc.	14,010,745	$34.47M	0.0%	+7.7%	7.749%
8/11/2023	Bridgewater Associates LP	192,212	$0.47M	0.0%	-8.2%	0.106%
8/11/2023	The Manufacturers Life Insurance Company	74,092	$0.18M	0.0%	+8.9%	0.041%
8/11/2023	Geode Capital Management LLC	3,520,846	$8.66M	0.0%	+4.0%	1.947%
8/11/2023	Northern Trust Corp	1,855,720	$4.57M	0.0%	+1.9%	1.026%
8/10/2023	Great West Life Assurance Co. Can	78,032	$0.19M	0.0%	+33.7%	0.043%
8/10/2023	Charles Schwab Investment Management Inc.	1,609,272	$3.96M	0.0%	+2.4%	0.890%
8/10/2023	Tamarack Advisers LP	1,750,000	$4.31M	1.3%	-22.2%	0.968%
8/10/2023	Citigroup Inc.	57,350	$0.14M	0.0%	+1,186.7%	0.032%
8/9/2023	BNP Paribas Arbitrage SNC	92,961	$0.23M	0.0%	+19.7%	0.051%
8/8/2023	Rhumbline Advisers	235,207	$0.58M	0.0%	+2.7%	0.130%
8/8/2023	Sepio Capital LP	393,345	$0.38M	0.0%	+32.7%	0.218%
8/8/2023	Wasatch Advisors LP	5,873,048	$14.45M	0.1%	+17.0%	3.253%
8/7/2023	Principal Financial Group Inc.	54,379	$0.13M	0.0%	+16.2%	0.030%
8/4/2023	Envestnet Asset Management Inc.	10,507	$26K	0.0%	N/A	0.006%
8/3/2023	Los Angeles Capital Management LLC	103,105	$0.25M	0.0%	+22.4%	0.057%
8/3/2023	Barclays PLC	1,186,464	$2.92M	0.0%	+80.7%	0.656%
8/3/2023	Bank of New York Mellon Corp	696,461	$1.71M	0.0%	+8.9%	0.386%
8/1/2023	Portside Wealth Group LLC	565,020	$1.39M	0.0%	N/A	0.313%
7/31/2023	Antonetti Capital Management LLC	182,735	$0.45M	0.6%	+51.4%	0.101%
7/31/2023	Sumitomo Mitsui Trust Holdings Inc.	8,236,491	$20.26M	0.0%	+2.7%	4.562%
7/27/2023	B. Riley Wealth Advisors Inc.	14,250	$35K	0.0%	N/A	0.008%
7/25/2023	Raymond James & Associates	950,112	$2.34M	0.0%	-13.0%	0.526%
7/25/2023	Assenagon Asset Management S.A.	94,544	$0.23M	0.0%	-82.2%	0.052%
7/24/2023	Dfpg Investments LLC	12,020	$35K	0.0%	N/A	0.007%
7/24/2023	Rice Hall James & Associates LLC	485,768	$1.20M	0.1%	-10.5%	0.269%
7/21/2023	Creative Planning	10,382	$26K	0.0%	N/A	0.006%
7/20/2023	Baker Tilly Wealth Management LLC	13,599	$33K	0.0%	N/A	0.008%
7/20/2023	Exchange Traded Concepts LLC	412,723	$1.02M	0.0%	+23.8%	0.229%
7/20/2023	Lesa Sroufe & Co	301,511	$0.74M	0.8%	-2.0%	0.167%
7/19/2023	Teacher Retirement System of Texas	13,430	$33K	0.0%	-31.9%	0.007%
7/14/2023	Bouvel Investment Partners LLC	246,850	$0.61M	0.3%	+5.5%	0.137%
7/14/2023	Xponance Inc.	10,375	$26K	0.0%	N/A	0.006%
7/10/2023	Quent Capital LLC	20,667	$51K	0.0%	N/A	0.011%
7/10/2023	ARK Investment Management LLC	20,657,391	$50.82M	0.3%	-6.5%	11.441%
7/10/2023	SG Americas Securities LLC	110,585	$0.27M	0.0%	-50.1%	0.061%
5/23/2023	Capital Impact Advisors LLC	120,915	$0.36M	0.4%	+7.2%	0.067%
5/22/2023	Ameriprise Financial Inc.	220,469	$0.66M	0.0%	-56.5%	0.122%
5/18/2023	JPMorgan Chase & Co.	137,230	$0.41M	0.0%	+10.1%	0.076%
5/18/2023	New York State Common Retirement Fund	71,881	$0.21M	0.0%	-33.3%	0.040%
5/16/2023	Silvercrest Asset Management Group LLC	2,203,590	$6.55M	0.0%	+13.6%	1.220%
5/16/2023	State Street Corp	4,810,020	$14.29M	0.0%	+15.1%	2.664%
5/16/2023	Geode Capital Management LLC	3,386,432	$10.06M	0.0%	+4.9%	1.876%
5/16/2023	AQR Capital Management LLC	112,347	$0.33M	0.0%	+33.8%	0.062%
5/15/2023	Cubist Systematic Strategies LLC	49,274	$0.15M	0.0%	-89.6%	0.027%
5/15/2023	Ionic Capital Management LLC	11,321	$34K	0.0%	N/A	0.006%
5/15/2023	Uniplan Investment Counsel Inc.	991,699	$2.95M	0.2%	-4.6%	0.549%
5/15/2023	Two Sigma Securities LLC	21,560	$64K	0.0%	+85.4%	0.012%
5/15/2023	Deutsche Bank AG	111,101	$0.33M	0.0%	+6.6%	0.062%
5/15/2023	Stephens Inc. AR	268,229	$0.80M	0.0%	-57.7%	0.149%
5/15/2023	Hood River Capital Management LLC	3,866,849	$11.49M	0.4%	-6.2%	2.142%
5/15/2023	XTX Topco Ltd	153,164	$0.46M	0.1%	+6.6%	0.085%
5/12/2023	Renaissance Technologies LLC	765,000	$2.27M	0.0%	+109.3%	0.424%
5/12/2023	Wasatch Advisors LP	5,018,439	$14.91M	0.1%	+3.2%	2.780%
5/12/2023	Stifel Financial Corp	191,664	$0.57M	0.0%	+90.6%	0.106%
5/12/2023	BlackRock Inc.	13,005,712	$38.63M	0.0%	+3.3%	7.203%
5/12/2023	BNP Paribas Arbitrage SNC	77,632	$0.23M	0.0%	+216.5%	0.043%
5/12/2023	Bank of America Corp DE	1,790,930	$5.32M	0.0%	+2,655.1%	0.992%
5/12/2023	UBS Group AG	200,825	$0.60M	0.0%	-71.8%	0.111%
5/12/2023	Dark Forest Capital Management LP	12,253	$36K	0.0%	N/A	0.007%
5/12/2023	Rice Hall James & Associates LLC	543,041	$1.61M	0.1%	-2.1%	0.301%
5/12/2023	Charles Schwab Investment Management Inc.	1,571,099	$4.67M	0.0%	-0.6%	0.870%
5/11/2023	FMR LLC	387,557	$1.15M	0.0%	-28.3%	0.215%
5/11/2023	Rhumbline Advisers	229,064	$0.68M	0.0%	+3.9%	0.127%
5/11/2023	Tamarack Advisers LP	2,250,000	$6.68M	2.4%	-10.0%	1.246%
5/10/2023	Credit Suisse AG	272,472	$0.81M	0.0%	+7.1%	0.151%
5/10/2023	Sepio Capital LP	296,490	$0.88M	0.1%	-43.4%	0.164%
5/10/2023	Swiss National Bank	382,900	$1.14M	0.0%	-10.5%	0.212%
5/9/2023	Tower Research Capital LLC TRC	12,383	$37K	0.0%	+793.4%	0.007%
5/9/2023	Bank of New York Mellon Corp	639,613	$1.90M	0.0%	-1.6%	0.354%
5/9/2023	Russell Investments Group Ltd.	67,072	$0.20M	0.0%	N/A	0.037%
5/8/2023	Public Employees Retirement Association of Colorado	117,957	$0.35M	0.0%	N/A	0.065%
5/5/2023	Versor Investments LP	67,900	$0.20M	0.0%	+410.5%	0.038%
5/4/2023	Barclays PLC	656,538	$1.95M	0.0%	+621.6%	0.370%
5/4/2023	Whitegate Investment Counselors Inc.	64,049	$0.19M	0.1%	+8.5%	0.036%

Data available starting January 2016

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.

Today's Range

Now: $1.50

$1.47

$1.58

50 Day Range

MA: $2.08

$1.50

$3.07

52 Week Range

Now: $1.50

$1.47

$4.25

Volume

666,909 shs

Average Volume

1,048,047 shs

Market Capitalization

$271.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Who are the company insiders with the largest holdings of Cerus?: Cerus' top insider investors include:
William Mariner Greenman (CEO)
Vivek K Jayaraman (COO)
Kevin Dennis Green (CFO)
Carol Moore (SVP)
Chrystal Menard (Insider)
Richard J Benjamin (Insider)
Daniel N Swisher Jr (Director)
Eric Bjerkholt (Director)
Ann Lucena (Director)
Gail Schulze (Director)
Laurence M Corash (Insider)
Learn More about top insider investors at Cerus.
Who are the major institutional investors of Cerus?: Cerus' top institutional investors include:
ARK Investment Management LLC — 11.44%
BlackRock Inc. — 7.75%
Sumitomo Mitsui Trust Holdings Inc. — 4.56%
Wasatch Advisors LP — 3.25%
Senvest Management LLC — 3.01%
State Street Corp — 2.84%
Learn More about top institutional investors of Cerus stock.
Which major investors are selling Cerus stock?: Within the last quarter, CERS stock was sold by these institutional investors:
ARK Investment Management LLC
Polar Capital Holdings Plc
Point72 Asset Management L.P.
Tamarack Advisers LP
Assenagon Asset Management S.A.
Renaissance Technologies LLC
Goldman Sachs Group Inc.
Raymond James & Associates
Within the previous year, company insiders that have sold Cerus company stock include:
William Mariner Greenman (CEO)
Vivek K Jayaraman (COO)
Kevin Dennis Green (CFO)
Carol Moore (SVP)
Chrystal Menard (Insider)
Richard J Benjamin (Insider)
Learn More investors selling Cerus stock.
Which major investors are buying Cerus stock?: During the previous quarter, CERS stock was bought by institutional investors including:
UniSuper Management Pty Ltd
BlackRock Inc.
Wasatch Advisors LP
Portside Wealth Group LLC
Barclays PLC
Silvercrest Asset Management Group LLC
State Street Corp
Sumitomo Mitsui Trust Holdings Inc.
Within the last year, these company insiders have bought Cerus stock:
William Mariner Greenman (CEO)
Vivek K Jayaraman (COO)
Learn More investors buying Cerus stock.